Emergent BioSolutions (EBS) Operating Margin (2011 - 2026)
Emergent BioSolutions (EBS) recorded Operating Margin of -53.39% in Q2 2026, down 54.53 percentage points from 1.14% a year earlier and down 60.12 percentage points from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Operating Margin (2011 - 2026) Analysis & Trends
On a TTM basis, Emergent BioSolutions' Operating Margin came in at -8.57% as of Jun 30, 2026, down 21.08 percentage points year-over-year; for FY2025, it was 13.47%, up 23.89 percentage points from FY2024.
- Annual Operating Margin has a five-year change of -14.33 percentage points (FY2020 to FY2025).
- Across earlier years, Operating Margin came in at -10.42% in FY2024 (+58.81 pp), -69.23% in FY2023 (-54.01 pp), -15.21% in FY2022 (-34.46 pp) and 19.25% in FY2021 (-8.55 pp).
- The Q2 2026 figure is the lowest quarterly Operating Margin since Q2 2024.
- On a year-over-year basis, Operating Margin has declined for three consecutive quarters, with an average year-over-year change of +17.46 percentage points over the last eight quarters.
- Peak year-over-year performance for Operating Margin in the last five years was a gain of 111.45 percentage points in Q3 2024, against a drop of 92.10 percentage points in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 6.73% (Q1 2026), -18.76% (Q4 2025) and 33.10% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,154.42 Bn | 1,123.00 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 623.43 Bn | 541.96 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 511.43 Bn | 484.54 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 365.39 Bn | 319.77 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 297.27 Bn | 261.26 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 261.21 Bn | 234.89 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 234.78 Bn | 190.18 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 192.99 Bn | 167.19 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.65 Bn | 118.30 Bn | 10.94 Bn | 28.37% |
| 10 | Emergent BioSolutions | 316.30 Mn | -434.60 Mn | 137.20 Mn | -53.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -53.39% |
| Mar 31, 2026 | 6.73% |
| Dec 31, 2025 | -18.76% |
| Sep 30, 2025 | 33.10% |
| Jun 30, 2025 | 1.14% |
| Mar 31, 2025 | 22.46% |
| Dec 31, 2024 | -4.88% |
| Sep 30, 2024 | 21.95% |
| Jun 30, 2024 | -79.90% |
| Mar 31, 2024 | 13.25% |
| Dec 31, 2023 | -15.84% |
| Sep 30, 2023 | -89.50% |
| Jun 30, 2023 | -86.68% |
| Mar 31, 2023 | -89.84% |
| Dec 31, 2022 | -16.75% |
| Sep 30, 2022 | -18.88% |
| Jun 30, 2022 | -31.45% |
| Mar 31, 2022 | 2.26% |
| Dec 31, 2021 | 39.13% |
| Sep 30, 2021 | -15.61% |
API Access
Emergent BioSolutions Operating Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-margin&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-margin", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-margin&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();